Morgan Stanley raises Arganex PT to $766 from $700, maintains Overweight rating

Morgan Stanley raises Arganex PT to $766 from $700, maintains Overweight rating

Morgan Stanley has raised its price target for Argenex (NASDAQ: ARGX) to $766 from $700, while maintaining its Overweight rating. The investment bank's analysts highlighted the company's strong earnings performance and promising product pipeline as key drivers for the upward revision.

Argenex reported earnings of $2.58 per share for the quarter, beating analysts' consensus estimates of $2.32 by $0.26. The company also achieved a return on equity of 16.15% and a net margin of 40.20%. Analysts at Morgan Stanley expect Argenex to post 3.13 earnings per share for the current year [3].

The analysts noted that Argenex's recent earnings results, along with its promising product pipeline, justify the higher price target. They also cited the company's strong balance sheet and attractive valuation as additional factors supporting their bullish outlook.

Institutional investors have shown confidence in Argenex, with several funds increasing their stakes in the company. Federated Hermes Inc. reduced its position in the first quarter but still owns 0.18% of the company's stock worth $64.48 million [3]. Other institutional investors, including GeoWealth Management LLC, FIL Ltd, Rakuten Securities Inc., Point72 Asia Singapore Pte. Ltd., and Huntington National Bank, have also increased their holdings in Argenex.

Argenex's stock performance has been robust, with shares opening at $598.79 on Wednesday and a 52-week high of $678.21. The company has a market capitalization of $36.65 billion, a price-to-earnings ratio of 36.94, a PEG ratio of 1.07, and a beta of 0.37.

Morgan Stanley's analysts remain optimistic about Argenex's growth prospects, particularly in light of the company's strong earnings performance and promising product pipeline. They expect the company to continue outperforming its peers and maintain its attractive valuation.

References:
[1] https://finance.yahoo.com/news/tesla-samsung-order-shift-unlikely-142836167.html
[2] https://finance.yahoo.com/news/know-beyond-why-morgan-stanley-130003585.html
[3] https://www.marketbeat.com/instant-alerts/filing-federated-hermes-inc-reduces-stake-in-argenex-se-nasdaqargx-2025-07-30/